Page results
-
Information about the integrated cancer care service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing and tissue diagnosis.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
The department specialises in the assessment and management of complex neuropsychiatric conditions occurring in the context of neurological disease.
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
File results
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details